Barry Ginsberg

US Patent:

7404796, Jul 29, 2008

Filed:

Mar 1, 2004

Appl. No.:

10/788475

Inventors:

Barry H. Ginsberg - Wyckoff NJ, US

Assignee:

Becton Dickinson and Company - Franklin Lakes NJ

International Classification:

A61B 5/00
A61B 5/05
A61M 31/00

US Classification:

600365, 600300, 604 65, 604 66

Abstract:

An apparatus and method are provided for determining a patient's carbohydrate to insulin ratio (CIR) and insulin sensitivity factor (ISF), and using these values, along with values for current blood glucose level and deviation from target blood glucose level, for determining insulin dose in view of carbohydrate intake during a particular time period. The apparatus and method employ algorithms that can be implemented in any of a personal computer, personal data assistant, hand held computing device, blood glucose monitor, infusion pump, medication delivery pen, meter, calculator, among other therapeutic, diagnostic or informational devices used for managing a patient's blood glucose levels.

US Patent:

7570980, Aug 4, 2009

Filed:

Sep 10, 2003

Appl. No.:

10/658209

Inventors:

Barry H. Ginsberg - Wyckoff NJ, US

Assignee:

Becton, Dickinson and Company - Franklin Lakes NJ

International Classification:

A61B 5/00

US Classification:

600347, 600365

Abstract:

A method of presenting glucose data to a person with diabetes from a blood glucose meter is provided in which an effective meal average (EMA) value is presented, followed by two or more of the individual values that make up the EMA, to provide improved feedback data for clinical decisions by patients who need to alter their dose of insulin. The EMA can also comprise a measure of the variability of its constituent values. The EMA encompasses those values that occur at specified times such as 1 hour before and 1 hour after a specified meal time. The EMA is calculated over a limited number of days previous to the calculation (e. g. , 3 days) and has a minimum number of values that must be obtained within the time and date ranges. An algorithm allows for exclusion of any given reading from the average (e. g. , post-prandial or control solution readings).

US Patent:

8246540, Aug 21, 2012

Filed:

Jul 1, 2008

Appl. No.:

12/216231

Inventors:

Barry H. Ginsberg - Wyckoff NJ, US

Assignee:

Becton, Dickinson and Company - Franklin Lakes NJ

International Classification:

A61M 31/00
A61B 5/05

US Classification:

600365, 604 66

Abstract:

An apparatus and method are provided for determining a patient's carbohydrate to insulin ratio (CIR) and insulin sensitivity factor (ISF), and using these values, along with values for current blood glucose level and deviation from target blood glucose level, for determining insulin dose in view of carbohydrate intake during a particular time period. The apparatus and method employ algorithms that can be implemented in any of a personal computer, personal data assistant, hand held computing device, blood glucose monitor, infusion pump, medication delivery pen, meter, calculator, among other therapeutic, diagnostic or informational devices used for managing a patient's blood glucose levels.

US Patent:

8285487, Oct 9, 2012

Filed:

Mar 23, 2007

Appl. No.:

12/293120

Inventors:

Chris Bergstrom - Ramsey NJ, US
Jay Butterbrodt - Andover MA, US
Alan W. Fiedler - Wayne NJ, US
Barry Ginsberg - Wyckoff NJ, US
Tim H. Gordon - Rivervale NJ, US
Paul Upham - Jersey City NJ, US

Assignee:

Becton, Dickinson and Company - Franklin Lakes NJ

International Classification:

G01N 33/48
G01N 33/00

US Classification:

702 19, 436 95

Abstract:

Methods, devices and a system for disease management are provided that employ diagnostic testing devices (e. g. , blood glucose meters) and medication delivery devices (e. g. , insulin delivery devices) for providing data to a repository in real-time and automatically. Repository data can be analyzed to determine such information as actual test strip use, patient health parameters to outside prescribed ranges, testing and medication delivery compliance, patient profiles or stakeholders to receive promotional items or incentives, and so on. Connected meters and medication delivery devices and repository data analysis are also employed to associate a diagnostic test to a mealtime based on timing of a therapeutic intervention performed by an individual.

US Patent:

20090240129, Sep 24, 2009

Filed:

Jun 3, 2009

Appl. No.:

12/457185

Inventors:

Barry H. Ginsberg - Wyckoff NJ, US

International Classification:

A61B 5/145

US Classification:

600365

Abstract:

A method of presenting glucose data to a person with diabetes from a blood glucose meter is provided in which an effective meal average (EMA) value is presented, followed by two or more of the individual values that make up the EMA, to provide improved feedback data for clinical decisions by patients who need to alter their dose of insulin. The EMA can also comprise a measure of the variability of its constituent values. The EMA encompasses those values that occur at specified times such as 1 hour before and 1 hour after a specified meal time. The EMA is calculated over a limited number of days previous to the calculation (e.g., 3 days) and has a minimum number of values that must be obtained within the time and date ranges. An algorithm allows for exclusion of any given reading from the average (e.g., post-prandial or control solution readings). Patients can use 1 to 8 EMA on any given date range (e.g., preferably 4, that is, breakfast, lunch, supper and bedtime snack).

US Patent:

20110184348, Jul 28, 2011

Filed:

Jul 17, 2009

Appl. No.:

12/737447

Inventors:

James Bates - Sparta NJ, US
Robert Banik - Long Valley NJ, US
Barry Ginsberg - Wyckoff NJ, US

International Classification:

A61M 5/142

US Classification:

604131

Abstract:

A high pressure delivery device for delivering a medicament includes a first chamber for storing a supply of the medicament and a second chamber in fluid communication with the first chamber. A fluid connection path is in fluid communication with the second chamber for administering the medicament. A valving system is in fluid communication with the first chamber, the second chamber and the fluid connection path. The valving system allows a dose of the medicament to be injected from the first chamber into the second chamber while substantially preventing backflow of the dose into the first chamber and substantially preventing leakage through the fluid connection path. The valving system also allows the dose in the second chamber to be administered through the fluid connection path while substantially preventing the dose from flowing back into the first chamber.

US Patent:

20130030841, Jan 31, 2013

Filed:

Aug 31, 2012

Appl. No.:

13/601163

Inventors:

Chris Bergstrom - Ramsey NJ, US
Jay Butterbrodt - Andover MA, US
Alan W. Fiedler - Wayne NJ, US
Barry Ginsberg - Wyckoff NJ, US
Tim H. Gordon - Rivervale NJ, US
Paul Upham - Jersey City NJ, US

International Classification:

G06Q 50/24

US Classification:

705 3

Abstract:

Methods, devices and a system for disease management are provided that employ diagnostic testing devices (e.g., blood glucose meters) and medication delivery devices (e.g., insulin delivery devices) for providing data to a repository in real-time and automatically. Repository data can be analyzed to determine such information as actual test strip use, patient health parameters to outside prescribed ranges, testing and medication delivery compliance, patient profiles or stakeholders to receive promotional items or incentives, and so on. Connected meters and medication delivery devices and repository data analysis are also employed to associate a diagnostic test to a mealtime based on timing of a therapeutic intervention performed by an individual.

US Patent:

50595440, Oct 22, 1991

Filed:

Jul 14, 1988

Appl. No.:

7/219020

Inventors:

Joachim N. Burghartz - Croton-on-Hudson NY
Barry J. Ginsberg - Yorktown Heights NY
Siegfried Mader - Croton-on-Hudson NY

Assignee:

International Business Machines Corp. - Armonk NY

International Classification:

H01L 21331

US Classification:

437 31

Abstract:

Selective and non-selective epitaxial growth is utilized to form a bipolar transistor having self-aligned emitter and base regions. A substrate of semiconductor material of a first conductivity type is provided and a first layer of semiconductor material of a second conductivity type is non-selectively epitaxially grown on the substrate. An insulating element is formed on a portion of the first layer of semiconductor material and a second layer of semiconductor material of the second conductivity type is selectively epitaxially grown on the first layer such that a portion of the second layer laterally overgrows onto an upper surface of the insulating element. The lateral overgrowth forms an aperture in the second layer to expose a region of the upper surface of insulating element. A layer of insulating material is formed on the second layer to isolate the second layer of semiconductor material from a subsequent deposition of conductive material. The portion of the insulating layer formed within the aperture narrows the aperture and the exposed region of the element.